Literature DB >> 8630916

Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.

X Sastre-Garau1, M Jouve, B Asselain, A Vincent-Salomon, P Beuzeboc, T Dorval, J C Durand, A Fourquet, P Pouillart.   

Abstract

BACKGROUND: The clinicopathologic features of infiltrating lobular carcinoma (ILC), which represents 5% to 15% of all breast cancers, are still controversial. In particular, the high frequency of multicentric lesions has led to questioning of the effectiveness of conservative treatment for this type of cancer. By studying a large number of cases, we aimed to compare the clinicopathological features of ILC with those of nonlobular infiltrating carcinoma (NLIC) and to assess the advisability of conservative therapy in the management of ILC.
METHODS: The population analyzed included 726 cases of ILC, 249 cases of mixed ILC/invasive ductal carcinoma (ILC/IDC), and 10,061 cases of NLIC. The age of patients, TNM status, estrogen- and progesterone-receptor status (ER, PR), and histologic grades of the 3 groups were compared. The follow-up was carried out on a subgroup of 5846 cases.
RESULTS: At diagnosis, ILC tumors were found to be larger on average and were detected in patients older than those with NLIC, but the degree of lymph node involvement was lower in patients with ILC than in NLIC. In ILC, tumors are more frequently grade I and ER-positive than in NLIC. Multicentric lesions were not significantly more frequent in ILC than in NLIC. The overall survival, locoregional control, disease free interval, and metastatic spread rates were not different among the three groups neither by univariate nor multivariate analysis, but the pattern of metastatic dissemination was different. In 480 cases of ILC considered for conservation therapy, the local recurrence and overall survival rates were similar to those observed for IDC.
CONCLUSIONS: Our analysis specifies the clinicopathological features of ILC and confirms that conservation therapy may be an appropriate treatment for this type of cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630916     DOI: 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  89 in total

1.  Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.

Authors:  Otto Metzger-Filho; Arlindo R Ferreira; Rinath Jeselsohn; William T Barry; Deborah A Dillon; Jane E Brock; Ines Vaz-Luis; Melissa E Hughes; Eric P Winer; Nancy U Lin
Journal:  Oncologist       Date:  2018-12-05

2.  Invasive lobular carcinoma of the breast presenting as retroperitoneal fibrosis: a case report.

Authors:  George M Yousef; Manal Y Gabril; Sahar Al-Haddad; Anna Marie Mulligan; R John Honey
Journal:  J Med Case Rep       Date:  2010-06-09

3.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Authors:  Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Rob Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

4.  MRI patterns of invasive lobular cancer: T1 and T2 features.

Authors:  G Levrini; C A Mori; R Vacondio; G Borasi; F Nicoli
Journal:  Radiol Med       Date:  2008-09-18       Impact factor: 3.469

Review 5.  [Lobular neoplasms and invasive lobular breast cancer].

Authors:  H-P Sinn; B Helmchen; J Heil; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

6.  Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast.

Authors:  David P Arps; Patrick Healy; Lili Zhao; Celina G Kleer; Judy C Pang
Journal:  Breast Cancer Res Treat       Date:  2013-03-28       Impact factor: 4.872

7.  Bilateral orbital tumour as the presentation of mammographically occult breast cancer.

Authors:  M Lell; R Schulz-Wendtland; A Hafner; A Magener; W A Bautz; B F Tomandl
Journal:  Neuroradiology       Date:  2004-07-08       Impact factor: 2.804

8.  Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breast.

Authors:  D J Hadjiminas; K E Zacharioudakis; M K Tasoulis; J C C Hu; S Lanitis; R Bright-Thomas; N G Dimopoulos; G Hornzee; D A Cunningham; S J Cleator; R Al Mufti
Journal:  Ann R Coll Surg Engl       Date:  2015-11       Impact factor: 1.891

9.  The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2003-08-22       Impact factor: 4.064

10.  A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.

Authors:  Jean-Philippe Meyniel; Paul H Cottu; Charles Decraene; Marc-Henri Stern; Jérôme Couturier; Ingrid Lebigot; André Nicolas; Nina Weber; Virginie Fourchotte; Séverine Alran; Audrey Rapinat; David Gentien; Sergio Roman-Roman; Laurent Mignot; Xavier Sastre-Garau
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.